Overbrook Management Corp In8 Bio, Inc. Transaction History
Overbrook Management Corp
- $370 Million
- Q1 2024
A detailed history of Overbrook Management Corp transactions in In8 Bio, Inc. stock. As of the latest transaction made, Overbrook Management Corp holds 33,756 shares of INAB stock, worth $27,004. This represents 0.01% of its overall portfolio holdings.
Number of Shares
33,756
Previous 33,756
-0.0%
Holding current value
$27,004
Previous $46,000
15.22%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding INAB
# of Institutions
33Shares Held
8.64MCall Options Held
0Put Options Held
0-
Aigh Capital Management LLC Baltimore, MD2.87MShares$2.3 Million1.37% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.42MShares$1.14 Million0.0% of portfolio
-
Ensign Peak Advisors, Inc Salt Lake City, UT1.12MShares$894,6120.0% of portfolio
-
683 Capital Management, LLC New York, NY615KShares$491,8030.06% of portfolio
-
Sigma Planning Corp Ann Arbor, MI515KShares$412,0640.02% of portfolio
About IN8BIO, INC.
- Ticker INAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,502,200
- Market Cap $19.6M
- Description
- IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidate includes INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of...